» Articles » PMID: 37829614

Experiences Administering Naloxone Among People in Different Social Roles: People Who Use Opioids and Family Members and Friends

Overview
Journal J Drug Issues
Date 2023 Oct 13
PMID 37829614
Authors
Affiliations
Soon will be listed here.
Abstract

Unintentional drug overdose deaths continue to be a critical public health issue. Naloxone, a nonscheduled, safe, and effective drug that reverses opioid-involved overdoses is available to non-medically trained individuals ("lay people"), but there is scant information about how people in different social roles experience naloxone administration. We conducted 24 in-depth interviews with people who use opioids (PWUO; = 15) and family members and friends of people who use opioids (FF; = 9) who had administered naloxone in response to an opioid overdose. Compared with PWUO, members of the FF group were less reticent to administer naloxone in response to an overdose. PWUO and FF had different perspectives of law enforcement and demonstrated varied knowledge of the Good Samaritan Law. While PWUO found that having and administering naloxone was empowering, FF took a more pragmatic approach, reporting the need for naloxone as an unfortunate reality of their loved one's drug use.

Citing Articles

Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky.

Knudsen H, Back-Haddix S, Andrews-Higgins S, Goetz M, Davis O, Oyler D Addict Sci Clin Pract. 2025; 20(1):27.

PMID: 40083021 PMC: 11907800. DOI: 10.1186/s13722-025-00553-2.

References
1.
Worthington N, Piper T, Galea S, Rosenthal D . Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J. 2006; 3:19. PMC: 1557479. DOI: 10.1186/1477-7517-3-19. View

2.
Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L . Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008; 103(10):1648-57. DOI: 10.1111/j.1360-0443.2008.02314.x. View

3.
Tesfaye Rogoza A, Dolatshahi J, Harocopos A, Paone D . Exploring willingness to engage with law enforcement among syringe service program participants in New York City. Int J Drug Policy. 2020; 78:102700. DOI: 10.1016/j.drugpo.2020.102700. View

4.
Bagley S, Forman L, Ruiz S, Cranston K, Walley A . Expanding access to naloxone for family members: The Massachusetts experience. Drug Alcohol Rev. 2017; 37(4):480-486. DOI: 10.1111/dar.12551. View

5.
Ariss T, Fairbairn C . The effect of significant other involvement in treatment for substance use disorders: A meta-analysis. J Consult Clin Psychol. 2020; 88(6):526-540. PMC: 7228856. DOI: 10.1037/ccp0000495. View